216 related articles for article (PubMed ID: 29856501)
21. RNA Editors, Cofactors, and mRNA Targets: An Overview of the C-to-U RNA Editing Machinery and Its Implication in Human Disease.
Lerner T; Papavasiliou FN; Pecori R
Genes (Basel); 2018 Dec; 10(1):. PubMed ID: 30591678
[TBL] [Abstract][Full Text] [Related]
22. APOBEC3s: DNA-editing human cytidine deaminases.
Silvas TV; Schiffer CA
Protein Sci; 2019 Sep; 28(9):1552-1566. PubMed ID: 31241202
[TBL] [Abstract][Full Text] [Related]
23. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
Petljak M; Green AM; Maciejowski J; Weitzman MD
Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
[TBL] [Abstract][Full Text] [Related]
24. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
Butler K; Banday AR
J Hematol Oncol; 2023 Mar; 16(1):31. PubMed ID: 36978147
[TBL] [Abstract][Full Text] [Related]
25. Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.
Roelofs PA; Martens JWM; Harris RS; Span PN
Clin Cancer Res; 2023 May; 29(9):1658-1669. PubMed ID: 36478188
[TBL] [Abstract][Full Text] [Related]
26. APOBEC3: Friend or Foe in Human Papillomavirus Infection and Oncogenesis?
Warren CJ; Santiago ML; Pyeon D
Annu Rev Virol; 2022 Sep; 9(1):375-395. PubMed ID: 35671565
[TBL] [Abstract][Full Text] [Related]
27. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
28. Similar deamination activities but different phenotypic outcomes induced by APOBEC3 enzymes in breast epithelial cells.
Granadillo Rodríguez M; Wong L; Chelico L
Front Genome Ed; 2023; 5():1196697. PubMed ID: 37324648
[TBL] [Abstract][Full Text] [Related]
29. APOBEC3A/B Polymorphism Is Not Associated with Human Papillomavirus Infection and Cervical Carcinogenesis.
Castilha EP; Curti RRJ; de Oliveira JN; Vitiello GAF; Guembarovski RL; Couto-Filho JD; Oliveira KB
Pathogens; 2023 Apr; 12(5):. PubMed ID: 37242306
[TBL] [Abstract][Full Text] [Related]
30. APOBECs orchestrate genomic and epigenomic editing across health and disease.
Cervantes-Gracia K; Gramalla-Schmitz A; Weischedel J; Chahwan R
Trends Genet; 2021 Nov; 37(11):1028-1043. PubMed ID: 34353635
[TBL] [Abstract][Full Text] [Related]
31. APOBEC3A catalyzes mutation and drives carcinogenesis in vivo.
Law EK; Levin-Klein R; Jarvis MC; Kim H; Argyris PP; Carpenter MA; Starrett GJ; Temiz NA; Larson LK; Durfee C; Burns MB; Vogel RI; Stavrou S; Aguilera AN; Wagner S; Largaespada DA; Starr TK; Ross SR; Harris RS
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32870257
[TBL] [Abstract][Full Text] [Related]
32. Integrated Analyses of the Expression and Prognostic Value of EPHB6 in Cervical Cancer and Its Correlation with Immune Infiltrates.
Xiang S; Wei M; Zhao L; Lin A; Xiong Z
J Oncol; 2023; 2023():2258906. PubMed ID: 37101747
[TBL] [Abstract][Full Text] [Related]
33. TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.
Yang J; Gao Y; Yao S; Wan S; Cai H
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083077
[TBL] [Abstract][Full Text] [Related]
34. Human APOBEC3B promotes tumor heterogeneity
Durfee C; Temiz NA; Levin-Klein R; Argyris PP; Alsøe L; Carracedo S; de la Vega AA; Proehl J; Holzhauer AM; Seeman ZJ; Lin YT; Vogel RI; Sotillo R; Nilsen H; Harris RS
bioRxiv; 2023 Feb; ():. PubMed ID: 36865194
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of APOBEC3 mutagenesis in human cancer cells.
Petljak M; Dananberg A; Chu K; Bergstrom EN; Striepen J; von Morgen P; Chen Y; Shah H; Sale JE; Alexandrov LB; Stratton MR; Maciejowski J
Nature; 2022 Jul; 607(7920):799-807. PubMed ID: 35859169
[TBL] [Abstract][Full Text] [Related]
36. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA.
Bergstrom EN; Luebeck J; Petljak M; Khandekar A; Barnes M; Zhang T; Steele CD; Pillay N; Landi MT; Bafna V; Mischel PS; Harris RS; Alexandrov LB
Nature; 2022 Feb; 602(7897):510-517. PubMed ID: 35140399
[TBL] [Abstract][Full Text] [Related]
37. HPV Meets APOBEC: New Players in Head and Neck Cancer.
Riva G; Albano C; Gugliesi F; Pasquero S; Pacheco SFC; Pecorari G; Landolfo S; Biolatti M; Dell'Oste V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573337
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-372 acts as a double-edged sword in human cancers.
Tajik F; Alian F; Yousefi M; Azadfallah A; Hoseini A; Mohammadi F; Karimi-Dehkordi M; Alizadeh-Fanalou S
Heliyon; 2023 May; 9(5):e15991. PubMed ID: 37251909
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analyses Reveal Effects on Tumor Immune Infiltration and Immunotherapy Response of APOBEC Mutagenesis and Its Molecular Mechanisms in Esophageal Squamous Cell Carcinoma.
Yang J; Xiang T; Zhu S; Lao Y; Wang Y; Liu T; Li K; Ma Y; Zhong C; Zhang S; Tan W; Lin D; Wu C
Int J Biol Sci; 2023; 19(8):2551-2571. PubMed ID: 37215984
[TBL] [Abstract][Full Text] [Related]
40. Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase.
Roelofs PA; Timmermans MAM; Stefanovska B; den Boestert MA; van den Borne AWM; Balcioglu HE; Trapman AM; Harris RS; Martens JWM; Span PN
Cells; 2023 Apr; 12(8):. PubMed ID: 37190094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
